HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael J Dowzicky Selected Research

Tigecycline (Tygacil)

9/2013Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.).
10/2012In vitro activity of tigecycline and comparators against organisms associated with intra-abdominal infections collected as part of TEST (2004-2009).
1/2012Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
9/2010In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008.
1/2010In vitro activity of tigecycline and comparators against a European compilation of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
8/2009Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
10/2008Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics.
11/2007Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.
7/2007Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial.
3/2007Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael J Dowzicky Research Topics

Disease

10Infections
01/2017 - 07/2005
3Intraabdominal Infections
10/2012 - 07/2005
2Soft Tissue Infections
08/2009 - 07/2005
1Bacterial Infections (Bacterial Infection)
01/2017
1Bacteremia
09/2010
1Cross Infection (Nosocomial Infection)
10/2008
1Streptococcal Infections (Streptococcal Infection)
03/2007
1Community-Acquired Infections
07/2005
1Sepsis (Septicemia)
07/2005
1Healthcare-Associated Pneumonia
07/2005
1Pneumonia (Pneumonitis)
07/2005
1Respiratory Tract Infections (Respiratory Tract Infection)
07/2005

Drug/Important Bio-Agent (IBA)

14Tigecycline (Tygacil)FDA Link
09/2013 - 07/2005
4CL 331002 (glycylcycline)IBA
03/2007 - 07/2005
2Anti-Infective Agents (Microbicides)IBA
01/2017 - 08/2009
1Anti-Bacterial Agents (Antibiotics)IBA
10/2008
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
07/2005
1FluoroquinolonesIBA
07/2005
1beta-LactamsIBA
07/2005
1Ampicillin (Omnipen)FDA LinkGeneric
07/2005
1AminoglycosidesIBA
07/2005
1Oxacillin (Prostaphlin)FDA LinkGeneric
07/2005
1Penicillins (Penicillin)FDA Link
07/2005
1TetracyclinesIBA
07/2005

Therapy/Procedure

1Length of Stay
01/2017
1Therapeutics
07/2005